Ironwood Pharmaceuticals Inc (IRWD) stock
IRWDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3062% below fair value
$4.85+0.02 (+0.41%)
Close on Nov 16, 2026Market cap $801.41MP/E 6.3Yield –
Ironwood Pharmaceuticals EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Ironwood Pharmaceuticals's EV/EBITDA was 3.1× on Nov 10, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 0.1× to 10.9×, with a median of 4.8×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 3.1× | −0.3 |
| 2025 | Dec 31, 2025 | 3.3× | −2.9 |
| 2024 | Dec 31, 2024 | 6.3× | +2.4 |
| 2023 | Jul 31, 2023 | 3.9× | −1.7 |
| 2022 | Dec 30, 2022 | 5.6× | −0.8 |
| 2021 | Dec 31, 2021 | 6.4× | −4.3 |
| 2020 | Dec 31, 2020 | 10.7× | −8.7 |
| 2019 | Dec 31, 2019 | 19.4× | – |
See a number that looks wrong?